Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
MXL 120mg capsules
0407020Q0BIADDV
|
MXL | Morphine sulfate | Central Nervous System | 312 |
|
Morphgesic SR 100mg tablets
0407020Q0BNADAH
|
Morphgesic | Morphine sulfate | Central Nervous System | 301 |
|
MXL 150mg capsules
0407020Q0BIAEDW
|
MXL | Morphine sulfate | Central Nervous System | 256 |
|
Morphine sulfate 60mg/2ml solution for injection ampoules
0407020Q0AAAMAM
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 238 |
|
MXL 200mg capsules
0407020Q0BIAFEI
|
MXL | Morphine sulfate | Central Nervous System | 231 |
|
Morphine sulfate 15mg/1ml solution for injection ampoules
0407020Q0AAACAC
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 177 |
|
Actimorph 1mg orodispersible tablets
0407020Q0BQACGG
|
Actimorph | Morphine sulfate | Central Nervous System | 171 |
|
MST Continus suspension 30mg granules sachets
0407020Q0BBAGCP
|
MST Continus | Morphine sulfate | Central Nervous System | 161 |
|
Morphine 20mg orodispersible tablets sugar free
0407020Q0AAGHGH
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 150 |
|
Morphine sulfate 5mg/5ml solution for injection ampoules
0407020Q0AAFZFZ
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 149 |
|
Morphine 90mg modified-release capsules
0407020Q0AADUDU
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 147 |
|
Morphine 30mg modified-release granules sachets sugar free
0407020Q0AACPCP
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 143 |
|
Actimorph 20mg orodispersible tablets
0407020Q0BQADGH
|
Actimorph | Morphine sulfate | Central Nervous System | 136 |
|
Morphine 120mg modified-release capsules
0407020Q0AADVDV
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 117 |
|
Morphine 150mg modified-release capsules
0407020Q0AADWDW
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 104 |
|
Morphine 1mg orodispersible tablets sugar free
0407020Q0AAGGGG
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 99 |
|
Morphine 200mg modified-release capsules
0407020Q0AAEIEI
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 92 |
|
Morphine 60mg modified-release granules sachets sugar free
0407020Q0AADCDC
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 79 |
|
Morphine sulfate 1mg/1ml solution for injection ampoules
0407020Q0AAA4A4
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 75 |
|
MST Continus suspension 60mg granules sachets
0407020Q0BBAHDC
|
MST Continus | Morphine sulfate | Central Nervous System | 66 |
|
Morphine 200mg modified-release tablets
0407020Q0AAAGAG
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 59 |
|
Actimorph 30mg orodispersible tablets
0407020Q0BQAEGI
|
Actimorph | Morphine sulfate | Central Nervous System | 35 |
|
MST Continus suspension 100mg granules sachets
0407020Q0BBAIDD
|
MST Continus | Morphine sulfate | Central Nervous System | 30 |
|
Morphine 30mg orodispersible tablets sugar free
0407020Q0AAGIGI
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 28 |
|
Morphine 100mg modified-release granules sachets sugar free
0407020Q0AADDDD
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 24 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.